astrazeneca Diagnostics
oncology projects Overview
As the Group Copy Supervisor for the AstraZeneca ENHERTU companion diagnostic work, I was the lead copywriter for the ScoreHER2low.com website in addition to all other training materials for pathologists and sales reps.
Enhertu cdx case study deck
I created this case study to show how our team moved the needle from relatively low awareness of HER2-low to a majority (90%) of pathologists being aware of the HER2-low classification in metastatic breast cancer. Most of the tactics our agency team created for the ENHERTU companion diagnostic can be found in this deck.
speaker deck / presentation
The purpose of this deck was to educate pathologists on HER2-low (IHC 1+ or IHC 2+/ISH–) being a new classification of HER2 expression in breast cancer.
I worked closely with the AZ clients as well as our internal Medical Directors and Art team to ensure scientific accuracy and best page layout for these data-heavy slides.
